Influence of clinical trials on current treatment strategy for Hodgkin's disease
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference47 articles.
1. A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IAIIB: a report from the Manchester lymphoma group;Anderson;Br. J. Cancer,1984
2. BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study;Bakemeier;Ann. Intern. Med.,1984
3. Results of treating Hodgkin's disease without a policy of laparotomy staging;Bergsagel;Cancer Treat. Rep.,1982
4. Chemotherapy strategies to improve the control of Hodgkin's disease. The Richard and Hinda Rosenthal Foundation Award Lecture;Bonadonna;Cancer Res.,1982
5. Alternating noncross-resistant combination chemotherapy or MOPP in Stage IV Hodgkin's disease. A report of 8-year results;Bonadonna;Ann. Intern. Med.,1986
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Assessment of the reporting quality of randomised controlled trials for vitamin D supplementation in autoimmune thyroid disorders based on the CONSORT statement;Endocrine;2022-12-03
2. Assessment of the reporting quality of double-blind RCTs for ischemic stroke based on the CONSORT statement;Journal of the Neurological Sciences;2020-08
3. Analysis of the Quality of Reporting of Randomized Controlled Trials in Acute and Chronic Myeloid Leukemia, and Myelodysplastic Syndromes as Governed by the CONSORT Statement;Annals of Epidemiology;2009-07
4. Reporting of Randomized Controlled Trials in Hodgkin Lymphoma in Biomedical Journals;JNCI: Journal of the National Cancer Institute;2006-05-03
5. Reducing Treatment-Related Morbidity and Mortality in Early-Stage Hodgkin’s Disease and Why the Recent Southwest Oncology Group Trial Is Not the Way to Go;Journal of Clinical Oncology;2002-05-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3